23andme.com (ME) - הון עצמי של החברה

The 23andMe Holding Co. (ME) chart on the GURU.Markets platform illustrates the price action of an asset with moderate cyclicality due to a combination of paid DNA tests and long-term pharmaceutical development, with the current indicator standing at 0.05. The business relies on a massive genomic dataset from millions of customers, positioning it as a valuable ally for drug developers. However, the company is currently fighting for survival amid falling demand and privacy concerns.

This indicator measures the real value of the organization's own property minus all liabilities, determining the business's internal resilience to external shocks. For 23andMe Holding Co. (ME), this metric demonstrates the material base supporting its leadership status in genetics and biomedicine, allowing for an assessment of the actual value of assets through the company's book capitalization level.